Specialists for Methotrexate toxicity

10 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Kjeld Schmiegelow, M.D.
Rare Disease / Clinical Research
Rigshospitalet, Denmark
QC-verified PI×3
Mikael Eriksson, MD PhD
Rare Disease / Clinical Research
Department of Oncology, Skåne University Hospital
PI×2
Roderick Johnson, MD
Rare Disease / Clinical Research
Leeds General Infirmary
PI×2
Richard E. Champlin, BS,MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×1
Jennifer H Foster, MD
Rare Disease / Clinical Research
Baylor College of Medicine
PI×1NORD CoE
Suzanne Kincaid, CCRA
Rare Disease / Clinical Research
BTG International Inc.
PI×1
Pinki Prasad, MD, MD, MPH
Rare Disease / Clinical Research
Vanderbilt-Ingram Cancer Center
NEW ORLEANS, LA
PI×1
John A Thompson
Rare Disease / Clinical Research
Oregon Health & Science University
2
Christopher P Fox
Rare Disease / Clinical Research
Nottingham University Hospital NHS Trust
2
Maha A Helal
Sohag University
PI×1

More about Methotrexate toxicity